Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)

SHE:300705 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	7,550	8,907	11,469	8,333	8,247	6,289
Market Cap Growth	-7.33%	-22.34%	37.63%	1.05%	31.12%	118.06%
Enterprise Value	7,386	8,564	11,228	8,362	8,274	6,265
Last Close Price	15.28	17.60	23.06	16.70	17.06	13.00
PE Ratio	16.68	17.38	31.14	30.90	40.38	76.46
Forward PE	12.47	14.62	26.14	21.80	31.87	-
PS Ratio	2.47	3.04	4.26	3.58	5.07	6.43
PB Ratio	2.80	3.53	5.81	5.37	7.50	7.53
P/TBV Ratio	2.97	3.69	6.09	5.70	8.07	8.02
P/FCF Ratio	60.32	25.56	2626.25	-	126.98	87.79
P/OCF Ratio	12.58	11.93	26.60	30.98	43.21	41.93
EV/Sales Ratio	2.42	2.92	4.17	3.60	5.08	6.41
EV/EBITDA Ratio	12.32	13.51	25.15	24.70	31.25	49.57
EV/EBIT Ratio	15.03	15.81	29.93	29.99	39.17	80.17
EV/FCF Ratio	59.01	24.57	2570.94	-	127.41	87.45
Debt / Equity Ratio	0.18	0.12	0.20	0.20	0.30	0.11
Debt / EBITDA Ratio	0.82	0.48	0.87	0.93	1.24	0.70
Debt / FCF Ratio	3.92	0.87	89.40	-	5.06	1.23
Asset Turnover	0.88	0.94	1.04	1.15	1.13	0.89
Inventory Turnover	2.21	2.50	2.46	2.29	1.99	1.75
Quick Ratio	3.40	3.01	2.76	2.12	2.12	1.80
Current Ratio	4.81	4.09	3.44	2.72	2.76	2.78
Return on Equity (ROE)	18.47%	22.77%	20.89%	20.34%	21.11%	10.30%
Return on Assets (ROA)	8.89%	10.84%	9.07%	8.62%	9.18%	4.44%
Return on Invested Capital (ROIC)	18.21%	24.41%	20.94%	21.94%	22.20%	9.08%
Return on Capital Employed (ROCE)	14.70%	18.20%	15.30%	15.00%	15.40%	8.20%
Earnings Yield	6.21%	5.75%	3.21%	3.24%	2.48%	1.31%
FCF Yield	1.66%	3.91%	0.04%	-1.73%	0.79%	1.14%
Dividend Yield	2.07%	1.78%	0.99%	1.01%	0.78%	0.17%
Payout Ratio	34.28%	22.58%	25.69%	25.70%	7.35%	16.74%
Buyback Yield / Dilution	-0.79%	2.34%	-9.55%	0.15%	-0.13%	1.89%
Total Shareholder Return	1.25%	4.12%	-8.56%	1.16%	0.66%	2.06%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.